Drug Research and Drug Development in the 21st Century (eBook, PDF)
Science and Ethics
Redaktion: Wolff, H. P.; Philipp, Egon O.; Fleckenstein, A.
73,95 €
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
37 °P sammeln
73,95 €
Als Download kaufen
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
37 °P sammeln
Jetzt verschenken
Alle Infos zum eBook verschenken
73,95 €
inkl. MwSt.
Sofort per Download lieferbar
Alle Infos zum eBook verschenken
37 °P sammeln
Drug Research and Drug Development in the 21st Century (eBook, PDF)
Science and Ethics
Redaktion: Wolff, H. P.; Philipp, Egon O.; Fleckenstein, A.
- Format: PDF
- Merkliste
- Auf die Merkliste
- Bewerten Bewerten
- Teilen
- Produkt teilen
- Produkterinnerung
- Produkterinnerung

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei
bücher.de, um das eBook-Abo tolino select nutzen zu können.
Hier können Sie sich einloggen
Hier können Sie sich einloggen
Sie sind bereits eingeloggt. Klicken Sie auf 2. tolino select Abo, um fortzufahren.

Bitte loggen Sie sich zunächst in Ihr Kundenkonto ein oder registrieren Sie sich bei bücher.de, um das eBook-Abo tolino select nutzen zu können.
Distinguished scientists and members of the medical profession discuss the research and development of safe and suitable drugs for the long-term treatment of chronic diseases. The book provides an up-to-date survey on new insights and technologies - as well as ethical considerations - , since traditional means and methods of drug research and drug development may no longer suffice to meet the challenges of the next century.
- Geräte: PC
- ohne Kopierschutz
- eBook Hilfe
- Größe: 51.95MB
Andere Kunden interessierten sich auch für
- Prostaglandin E1 (eBook, PDF)73,95 €
- Clinical Pharmacology: Current Topics and Case Studies (eBook, PDF)185,95 €
- Rökan (eBook, PDF)73,95 €
- John GeigertThe Challenge of CMC Regulatory Compliance for Biopharmaceuticals (eBook, PDF)161,95 €
- Pharmacological Mechanisms in Alzheimer's Therapeutics (eBook, PDF)113,95 €
- Antimalarial Drugs I (eBook, PDF)73,95 €
- Stereochemical Aspects of Drug Action and Disposition (eBook, PDF)40,95 €
-
-
-
Distinguished scientists and members of the medical profession discuss the research and development of safe and suitable drugs for the long-term treatment of chronic diseases. The book provides an up-to-date survey on new insights and technologies - as well as ethical considerations - , since traditional means and methods of drug research and drug development may no longer suffice to meet the challenges of the next century.
Dieser Download kann aus rechtlichen Gründen nur mit Rechnungsadresse in A, B, BG, CY, CZ, D, DK, EW, E, FIN, F, GR, HR, H, IRL, I, LT, L, LR, M, NL, PL, P, R, S, SLO, SK ausgeliefert werden.
Produktdetails
- Produktdetails
- Verlag: Springer Berlin Heidelberg
- Seitenzahl: 310
- Erscheinungstermin: 6. Dezember 2012
- Englisch
- ISBN-13: 9783642746154
- Artikelnr.: 53093498
- Verlag: Springer Berlin Heidelberg
- Seitenzahl: 310
- Erscheinungstermin: 6. Dezember 2012
- Englisch
- ISBN-13: 9783642746154
- Artikelnr.: 53093498
- Herstellerkennzeichnung Die Herstellerinformationen sind derzeit nicht verfügbar.
History and Philosophy of Bayer Pharmaceutical Research.- Science, Responsibility, and Society.- Opening Remarks.- Message of Greeting.- I. Unresolved Problems of Chronic Diseases.- Demographic and Epidemiologic Trends Today.- Atherosclerosis and Coronary Heart Disease.- Rheumatoid Arthritis: A Modell of Chronic Inflammation.- Alzheimer's Disease.- Obstructive Lung Disease.- Biological Approaches to Cancer Therapy.- Challenges and Obstacles hi Clinical Evaluations of Therapy.- Problems, Pitfalls, and Opportunities in Long-term Randomized Trials.- The Impact of Clinical Trials on Clinical Practice.- Panel Discussion I: Cost Effectiveness of Drug Development and Health Economics.- II. Advanced Technologies, Scientific Achievements.- Receptors and Messengers.- Low Density Lipoproteins and Hypercholesterolemia.- Leukotrienes in Airways and Blood Vessels.- Drug Design.- Opening Remarks.- Thoughts About Gene Regulation and Mammalian Development.- Protein Crystallography and Drug Design.- Applying Engineering Principles to the Design of Cellular Biology.- Analytical Pathophysiology and Biochemistry.- Opening Remarks.- Neurotransmitters in the Brain.- Mechanisms of Cancer Metastasis.- Panel Discussion II: Objectives of Basic Research and Predictive Value Preclinical Testing.- The Patient as a Subject to Medical Research.- Ethics of Drug Research and Drug Development.- The Functions of Ethical Committees.- Reduction of Risk to Patients Through Optimized Planning of Clinical Drug Development.- The Quality of Life of Hypertensive Patients in Long-term Studies.- Panel Discussion III: Who is Concerned with Patient Welfare in Research?.- Concluding Remarks.
History and Philosophy of Bayer Pharmaceutical Research.- Science, Responsibility, and Society.- Opening Remarks.- Message of Greeting.- I. Unresolved Problems of Chronic Diseases.- Demographic and Epidemiologic Trends Today.- Atherosclerosis and Coronary Heart Disease.- Rheumatoid Arthritis: A Modell of Chronic Inflammation.- Alzheimer's Disease.- Obstructive Lung Disease.- Biological Approaches to Cancer Therapy.- Challenges and Obstacles hi Clinical Evaluations of Therapy.- Problems, Pitfalls, and Opportunities in Long-term Randomized Trials.- The Impact of Clinical Trials on Clinical Practice.- Panel Discussion I: Cost Effectiveness of Drug Development and Health Economics.- II. Advanced Technologies, Scientific Achievements.- Receptors and Messengers.- Low Density Lipoproteins and Hypercholesterolemia.- Leukotrienes in Airways and Blood Vessels.- Drug Design.- Opening Remarks.- Thoughts About Gene Regulation and Mammalian Development.- Protein Crystallography and Drug Design.- Applying Engineering Principles to the Design of Cellular Biology.- Analytical Pathophysiology and Biochemistry.- Opening Remarks.- Neurotransmitters in the Brain.- Mechanisms of Cancer Metastasis.- Panel Discussion II: Objectives of Basic Research and Predictive Value Preclinical Testing.- The Patient as a Subject to Medical Research.- Ethics of Drug Research and Drug Development.- The Functions of Ethical Committees.- Reduction of Risk to Patients Through Optimized Planning of Clinical Drug Development.- The Quality of Life of Hypertensive Patients in Long-term Studies.- Panel Discussion III: Who is Concerned with Patient Welfare in Research?.- Concluding Remarks.